🇺🇸 FDA
Patent

US 10870687

Anti-human papillomavirus 16 E7 T cell receptors

granted A61KA61K38/00A61K38/1774

Quick answer

US patent 10870687 (Anti-human papillomavirus 16 E7 T cell receptors) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K38/00, A61K38/1774, A61P, A61P1/00